Press release
Ascites Market Dynamics, Key Players, Growth Drivers, and Strategic Forecast
Ascites Market
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71107
In a Nutshell
• Market Size (2024): USD 1.5 Billion
• Forecast (2034): USD 2.9 Billion
• CAGR (2025-2034): 7.2%
• Key Growth Driver: Rising prevalence of cirrhosis and liver-related disorders, coupled with advances in treatment options
• Top Region: North America dominates due to high diagnosis rates, strong healthcare infrastructure, and access to transplantation
• Top Application: Hospitals account for the largest share in ascites treatment procedures
• Leading Players: F. Hoffmann-La Roche, Novartis, Pfizer, Gilead Sciences, Takeda, Mallinckrodt, Sanofi, Johnson & Johnson, Merck, Fresenius SE & Co. KGaA
• Major Trends: Expansion of albumin therapy, minimally invasive procedures (TIPS), regenerative medicine, digital health monitoring in hepatology
• Recent Developments (2025): Key pharma and biotech companies expanded liver therapy portfolios, introduced affordability programs, and launched new devices for ascites management
Market Overview
The global ascites market is expected to expand steadily due to:
• Rising incidence of liver cirrhosis, alcoholic liver disease, hepatitis B & C, and NAFLD/NASH
• Increasing use of paracentesis and albumin infusion as first-line therapies
• Expanding adoption of TIPS procedures and transplantation for refractory ascites
• Improved availability of hospital infrastructure and diagnostic tools in emerging markets
• Growing investments in hepatology research and rare liver disorder treatment
While paracentesis remains the standard of care, drug therapies, device-based interventions, and transplant innovations are driving strong market potential.
Key Market Drivers
1. Rising Burden of Chronic Liver Disease
Cirrhosis is the leading cause of ascites, and its increasing prevalence directly fuels market demand.
2. Expansion of Albumin Therapy
Albumin infusion is gaining adoption globally due to its role in improving circulatory function and patient outcomes.
3. Adoption of Minimally Invasive Interventions
Procedures like TIPS are increasingly preferred for refractory ascites, enhancing survival rates.
4. Government & NGO Support
Programs for viral hepatitis elimination and alcohol harm reduction indirectly expand the ascites treatment market.
Key Restraints and Challenges
• High Treatment Costs: Albumin therapy and transplantation are expensive, limiting accessibility.
• Limited Donor Availability: Transplantation is constrained by organ shortages.
• High Relapse Rates: Ascites often recurs despite repeated interventions.
• Access Gaps in Emerging Regions: Infrastructure and affordability remain barriers in developing economies.
Opportunities & Trends
• Stem Cell & Regenerative Medicine: Research into hepatocyte regeneration offers curative potential.
• Digital Health in Hepatology: AI-driven liver health monitoring tools are emerging.
• Collaborative Clinical Research: Pharma-academia partnerships are expanding ascites trial pipelines.
• Biosimilars & Cost-effective Albumin: Expanding biosimilars will reduce costs and increase adoption.
Market Segmentation
By Treatment Type
• Paracentesis
• Diuretics (spironolactone, furosemide, etc.)
• Albumin Therapy
• Transjugular Intrahepatic Portosystemic Shunt (TIPS)
• Liver Transplantation
• Supportive Care
By End-User
• Hospitals
• Specialty Clinics
• Research Institutes
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/71107/ascites-market
Regional Insights
North America
North America leads the ascites market with strong transplantation programs, advanced hepatology infrastructure, and early adoption of albumin therapies. The U.S. accounts for the largest share due to its high burden of NAFLD/NASH and alcohol-related liver disease.
Europe
Europe is the second-largest market, supported by Germany, France, Italy, and the UK, where robust healthcare systems, reimbursement frameworks, and clinical research in hepatology boost treatment adoption.
Asia-Pacific
APAC is projected to post the fastest CAGR, driven by the high prevalence of hepatitis B & C, alcohol misuse, and growing healthcare investment. China, India, and Japan are key contributors, with improving access to advanced liver treatments.
Latin America
Moderate growth is expected in Brazil and Mexico, where liver disease prevalence is high but healthcare infrastructure is gradually advancing.
Middle East & Africa
MEA remains smaller but is expanding steadily with GCC initiatives in rare disease treatment and liver care programs supported by NGOs.
Competitive Landscape
The ascites market includes major pharma and medtech players focusing on albumin therapies, diuretics, liver transplantation research, and device-based procedures.
Key Players (as per report):
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Pfizer Inc.
• Gilead Sciences Inc.
• Takeda Pharmaceutical Company
• Mallinckrodt Pharmaceuticals
• Sanofi
• Johnson & Johnson
• Merck & Co.
• Fresenius SE & Co. KGaA
These players are focusing on drug innovations, biosimilars, transplantation support, and global partnerships to strengthen their positions in the ascites market.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71107
Recent Developments (2025)
1. Fresenius (Jan 2025): Expanded global distribution of its albumin portfolio to improve ascites therapy affordability.
2. Gilead Sciences (Feb 2025): Announced a real-world study on antiviral use in hepatitis-related ascites cases.
3. Takeda (Mar 2025): Partnered with a Japanese institute to advance stem cell therapy research for refractory ascites.
4. Novartis (Apr 2025): Launched a digital liver monitoring platform for ascites patients in Europe.
5. Mallinckrodt (May 2025): Introduced a patient affordability program in LATAM for rare liver disease therapies including ascites care.
Events and Implications
• Albumin Therapy Expansion: Widespread use of albumin is reshaping treatment protocols.
• Device Innovation: TIPS and new paracentesis devices are improving patient survival rates.
• Stem Cell Research: Regenerative medicine holds promise for long-term liver repair.
• Regional Inequality Persists: Developed markets dominate adoption, while APAC leads in patient pool growth.
Conclusion
The Ascites Market is set for significant expansion between 2025 and 2034, driven by the rising prevalence of liver disease, expanding use of albumin therapy, and innovations in TIPS and transplantation.
North America and Europe will dominate revenues, while Asia-Pacific is expected to be the fastest-growing region due to its high hepatitis burden and expanding healthcare investment.
With Fresenius, Gilead, Novartis, Takeda, and Roche leading innovation across therapies and devices, the ascites market is entering a new era of improved treatment accessibility and patient outcomes.
This report is also available in the following languages : Japanese (腹水市場), Korean (복수 시장), Chinese (腹水市场), French (Marché de l'ascite), German (Aszites-Markt), and Italian (Mercato dell'ascite), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71107/ascites-market#request-a-sample
Our More Reports:
Sedation Market
https://exactitudeconsultancy.com/reports/71024/sedation-market
Spinal Muscular Atrophy (SMA) Market
https://exactitudeconsultancy.com/reports/71026/spinal-muscular-atrophy-sma-market
Status Epilepticus Market
https://exactitudeconsultancy.com/reports/71028/status-epilepticus-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ascites Market Dynamics, Key Players, Growth Drivers, and Strategic Forecast here
News-ID: 4158027 • Views: …
More Releases from Exactitude Consultancy
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571
In recent years, however, the…
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to…
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can…
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies.
Download…
More Releases for Mar
Consumer Adoption Of Smartphones And Tablets Fuels The Mobile Augmented Reality …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Mobile Augmented Reality (MAR) Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size of mobile augmented reality (MAR) has been expanding dramatically. The market is projected to increase from $27.57 billion in 2024 to $37.19 billion in 2025, with a compound annual growth…
1 New Article from Happy Smoking - MAR 2025
Happy Smoking is your definitive guide to smoking culture, providing expert reviews, comprehensive guides, and a platform for aficionados to connect and share their passion. We offer responsible, accurate information on enjoying cigars, pipes, and hookahs
.
Austin, TX - MAR 2025: Happy Smoking, a leader in smoking guides and expert reviews, is thrilled to announce the publishing of 1 new article on our platform. This month's update includes a diverse range…
Bungalows Del Mar Office by Harbor Associates in Del Mar, California Defies Nati …
Image: https://www.abnewswire.com/upload/2025/01/5bf83fc4238a3b3089be31e9b2ba64df.jpg
Seal Beach, CA - January 17, 2025 - Harbor Associates, LLC ("Harbor"), a value add and opportunistic buyer and owner in the office market, completed the lease up of the Bungalows Del Mar Office (https://www.thebungalowsdelmar.com/) despite the pandemic and work from home trends and now the recession that has slowed traditional office leasing. This Del Mar office space created by Harbor has been so successful that a rare…
Sport Sunglasses Market is Booming Worldwide | Oakley, Tifosi, Costa Del Mar
A Latest intelligence report published by AMA Research with title "Global Sport Sunglasses Market Outlook to 2028. A detailed study accumulated to offer Latest insights about acute features of the Sport Sunglasses market. This report provides a detailed overview of key factors in the Global Sport Sunglasses Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development.
Definition:
Sport sunglasses are specialized eyewear designed to…
Mobile Augmented Reality (MAR) Market 2021 | Detailed Report
The Mobile Augmented Reality (MAR) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the…
Casa Del Mar - Bronx's Exquisite Bar and Restaurant
Bronx, New York City, Release: March 19, 2020
Seafood Dining at Its Best
Are you on a seafood diet?
If you are on a seafood diet, then what's better than sitting at Casa Del Mar, get hooked on seafood at a beautiful restaurant located in the heart of the Bronx that features the most exquisite seafood cuisine of all times.
Established on, the restaurant is an ideal seafood destination for all the gastronomes and…
